Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e96496a9949403e2af2ca913e65bfec |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-3061 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-30 |
filingDate |
1986-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2dcdcbc2eb4fa51911187b069dd1bd35 |
publicationDate |
1986-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-8607089-A1 |
titleOfInvention |
Murine hybridoma lym-2 and diagnostic antibody produced thereby |
abstract |
Hybridoma Lym-2 (ATCC No. HB 8613) produces murine IgG1 monoclonal antobodies specifically against normal human B cells and derived malignancies. The Lym-2 antibodies have possible clinical utility for the in vivo diagnosis and therapy of human B-cell lymphomas and leukemias. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0316462-A1 |
priorityDate |
1985-05-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |